STOCK TITAN

Ishwar K. Puri Files Initial Form 3 for NeOnc (NTHI); Zero Holdings Reported

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

NeOnc Technologies Holdings, Inc. (NTHI) Form 3 shows that Ishwar K. Puri, identified as a director, filed an initial Section 16 statement related to an 08/18/2025 event. The filing states explicitly that no securities are beneficially owned by the reporting person. The form is individually filed and bears the reporting person’s signature dated 09/05/2025. No non‑derivative or derivative holdings are listed on the schedules.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
PURI ISHWAR KANWAR

(Last) (First) (Middle)
23975 PARK SORRENTO
SUITE 205

(Street)
CALABASAS CA 91302

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/18/2025
3. Issuer Name and Ticker or Trading Symbol
NEONC TECHNOLOGIES HOLDINGS, INC. [ NTHI ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
No securities are beneficially owned.
/s/ Ishwar K. Puri 09/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 3 for NeOnc (NTHI) filed by Ishwar K. Puri report?

The Form 3 reports that Ishwar K. Puri is a director and reported no securities beneficially owned as of the event date 08/18/2025.

Was the Form 3 filed jointly or by one reporting person for NTHI?

The filing indicates the Form was filed by one reporting person (not jointly).

Are there any derivative or non‑derivative securities listed in the filing?

No. The schedules show no non‑derivative or derivative securities beneficially owned by the reporting person.

What signature and date appear on the Form 3 for NTHI?

The form is signed /s/ Ishwar K. Puri with a signature date of 09/05/2025.

What is the reporting person’s address listed on the Form 3?

The address provided is 23975 Park Sorrento, Suite 205, Calabasas, CA 91302.
NeOnc Technologies Holdings Inc

NASDAQ:NTHI

NTHI Rankings

NTHI Latest News

NTHI Latest SEC Filings

NTHI Stock Data

200.16M
4.97M
52.63%
3.18%
0.64%
Biotechnology
Pharmaceutical Preparations
Link
United States
CALABASAS